(Q40387008)

20 September 2017

1 reference

title

Treatment of minimal residual disease in myeloid leukemia--the immunotherapeutic options with emphasis on Linomide (English)

1 reference

20 September 2017

1 reference

1 reference

Rowe JM

1

1 reference

20 September 2017

Nilsson BI

series ordinal

2

1 reference

20 September 2017

Simonsson B

series ordinal

3

1 reference

20 September 2017

publication date

1 November 1993

1 reference

20 September 2017

1 reference

20 September 2017

volume

11

1 reference

20 September 2017

issue

5-6

1 reference

20 September 2017

page(s)

321-329

1 reference

Spontaneous remission of acute myeloid leukemia. A report of a case and brief review of the literature

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067922

Acute nonlymphoblastic leukemia: prognostic factors in adults with long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067922

Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067922

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067922

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067922

Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remission.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067922

Inducibility of lymphokine activated killer (LAK) cells in patients with acute myelogenous leukaemia in complete remission and its clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067922

Inhibition of lymphokine-activated killer cell generation by cultured tumor cell lines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067922

Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067922

Induction of graft-versus-host disease after autologous bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067922

Immunotherapy of cancer using interleukin 2: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067922

Thrombocytopenia during immunotherapy with interleukin-2 by constant infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067922

Enhanced NK cell activity in mice injected with interferon and interferon inducers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067922

Immunosuppressive effects of recombinant interferon-alpha during long-term treatment of cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067922

The role of interferon in the regulation of virus infections by cytotoxic lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067922

10.3109/10428199309067922

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference